Boston Scientific (BSX) Net Cash Flow Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -54.17% |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | 98.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -395.56% |
| Mar 31, 2026 | -283.58% |
| Dec 31, 2025 | 132.84% |
| Sep 30, 2025 | 276.32% |
| Jun 30, 2025 | -131.80% |
| Mar 31, 2025 | -81.08% |
| Dec 31, 2024 | -2,411.11% |
| Sep 30, 2024 | -180.85% |
| Jun 30, 2024 | 507.19% |
| Mar 31, 2024 | 498.90% |
| Dec 31, 2023 | -112.96% |
| Sep 30, 2023 | 1,023.91% |
| Jun 30, 2023 | -110.61% |
| Mar 31, 2023 | 77.84% |
| Dec 31, 2022 | 6,844.44% |
| Sep 30, 2022 | 106.25% |
| Jun 30, 2022 | -110.23% |
| Mar 31, 2022 | -730.00% |
| Dec 31, 2021 | 103.07% |
| Sep 30, 2021 | -377.74% |